Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
International Journal of Molecular Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1107-3756 Online ISSN: 1791-244X
Journal Cover
March 2013 Volume 31 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
March 2013 Volume 31 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Aquaporin 1 plays an important role in myocardial edema caused by cardiopulmonary bypass surgery in goat

  • Authors:
    • Yumei Yan
    • Jianbin Huang
    • Fangbao Ding
    • Ju Mei
    • Jiaquan Zhu
    • Hao Liu
    • Kun Sun
  • View Affiliations / Copyright

    Affiliations: Department of Cardiothoracic Surgery, Xinhua Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200092, P.R. China
  • Pages: 637-643
    |
    Published online on: January 3, 2013
       https://doi.org/10.3892/ijmm.2013.1228
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Myocardial stunning, which is closely related to myocardial edema, is a severe complication that may occur following cardiac surgery. In this study, we examined the expression of aquaporin 1 (AQP1) and Connexin 43 (Cx43) following cardiopulmonary bypass (CPB) surgery in goats. We assessed myocardial muscle tissue water content according to changes in dry-wet weight. Our results showed that AQP1 expression and myocardial muscle tissue water content increased significantly 6 h after CPB surgery, reaching peak levels 48 h after surgery; additionally, the protein expression of Cx43 was inversely correlated with AQP1 expression. Overexpression of AQP1 during CPB surgery enhanced the degree of myocardial edema, whereas the addition of water channel protein inhibitor Hg2+ in cold crystalloid cardioplegia and knockdown of AQP1 during surgery weakened the degree of myocardial edema. These findings revealed that the severity of myocardial edema after CPB surgery is correlated with AQP1 protein expression levels, suggesting the important role played by AQP1 protein in the regulation of Cx43 in the pathological progression of myocardial edema.

Introduction

Myocardial edema is closely related to myocardial stunning, and may lead to death or complications following surgery. Heart dysfunction caused by myocardial edema can dramatically affect both systolic and diastolic function, and may endure over a long period of time (1,2). It has been previously demonstrated that a water content increase of 3.5% can lead to a cardiac output decrease of 30 to 50% (3,4). Myocardial edema is caused by ischemia-reperfusion injury, hemodilution during cardiopulmonary bypass (CPB), and an inflammatory response to CPB (5,6).

Aquaporin water channels are comprised of highly conserved proteins that exist in both bacteria and humans. These water channels are involved in many physiological processes, such as the osmotic environment and overall body fluid balance, including osmotically driven transepithelial fluid transport that occurs in the kidney, eye and secretory glands, and facilitation of water movement into and out of the brain in various pathologies such as stroke, tumor and infection (7–10). There are 13 members of AQPs (AQP0-AQP12) in animals and their expression is organ-specific. Aquaporin 1 (AQP1) is the most predominant and least tissue expression-specific subtype. The monomeric structure consists of two triple transmembrane helices connected by a long flexible extracellular loop. Studies in rodents have demonstrated that AQP1 is expressed in cardiac muscle cells and that it can be reversibly internalized from the cell membrane in response to the osmotic environment (10–12).

Cardiac myocytes are tightly interconnected by means of highly specialized regions of the plasma membrane called gap junctions. Gap junctions are composed of clusters of transmembrane channels connecting the cytosol of adjacent cells. Studies have demonstrated that Connexin 43 (Cx43) plays an important role in myocardial protection in ischemic preconditioning (13–15), but whether it plays the same role in myocardial edema remains unknown.

In this study, we demonstrated the variations in mRNA expression and protein levels of AQP1 following CPB surgery in a goat animal model. To maintain constant extracellular volume, water is cleared from the cytoplasm via gap junctions. We also tested whether a functional relationship exists between water channels and gap junctions. We found that AQP1 plays an important role in myocardial edema via regulation of Cx43 expression.

Materials and methods

Animal model

The study protocol was approved by the Medical Ethics Committee of Shanghai Xinhua Hospital, conforms to the Principles of Laboratory Animal Care (National Society for Medical Research), and was conducted according to National Institutes of Health guidelines.

Twenty-four adult goats weighing 50–60 kg (Slac Laboratory Animal) were used for this study. Myocardium tissues from the left and right cardiac ventricles were obtained from six adult goats anesthetized and bled from the dorsal aorta until expiration. Tissues were stored in liquid nitrogen for further use.

Animal studies and extracorporeal circulation model

The goats underwent general anesthesia with isoflurane and nitrous oxide, and were endotracheally intubated. A left anterolateral thoracotomy was performed in the fifth intercostal space, followed by dissection. After systemic anticoagulation with sodium heparin (300 U/kg), the aorta was cannulated for arterial perfusion. A venous cannula was placed in the right atrium. Upon initiation of CPB surgery, the body temperature was cooled to 28°C and the aorta was cross-clamped. The heart was arrested with crystalloid cardioplegic solution.

The pericardial cavity was filled with cold physiological saline after cardiac arrest and perfused with crystalloid cardioplegic solution every 20 min. Following 60 min of cardiac arrest, the aorta was declamped. All animals were weaned from CPB without inotropic support 60 min after the release of the aortic cross-clamp. Protamine was used to neutralize the heparin. Following placement of the drainage tube, the thoracic cavity was closed.

Myocardium tissue samples from the left and right cardiac ventricles were obtained 0, 2, 6, 12, 24, 48 and 72 h following CPB, and stored in liquid nitrogen until further use.

Real-time PCR analysis of AQP1 expression

Real-time PCR was performed to assess AQP1 expression in the left ventricle (LV) and right ventricle (RV). Heart tissue was homogenized and RNA was isolated using RNeasy Fibrous Tissue Mini kit (Qiagen) according to the manufacturer’s protocol, and any contaminating DNA was degraded by a 15-min incubation with RNase-free DNase. Real-time PCR was performed using the High Capacity cDNA Archive kit (Applied Biosystems). We created two standard curves, one for mouse AQP1 and the other using the internal control GAPDH with real-time PCR using appropriate primers and probes (Applied Biosystems). Each sample was loaded in triplicate for both AQP1 and GAPDH. The primers for AQP1 were: forward, 5′-GCC AGC GAG TTC AAG AAG-3′ and reverse, 5′-CCC CAC CCA GAA AAT CC-3′. The primers for GAPDH were: forward, 5′-GCC AGC GAG TTC AAG AAG-3′ and reverse, 5′-CCC CAC CCA GAA AAT CC-3′. Real-time PCR was conducted using the ABI Prism 7000 sequence detection system, and data were analyzed with ABI Prism 7300 SDS software.

Western blot analysis

Western blot analysis was performed as described previously (16), with minor modifications. In brief, each goat myocardium tissue sample was crushed and ground using a mortar, pestle and liquid nitrogen. The resulting powder was immediately suspended in lysis buffer (pH 7.4, 4% SDS, 100 mM DTT, 125 mM Tris, 40% glycerol and trace cocktail protease inhibitor), and ultrasonically homogenized. Next, the solution was heated to 94°C for 4 min, and the cell debris and insoluble substances were removed by centrifugation at 15,000 × g for 3 min. The supernatant was separated by SDS-PAGE with 20 μg protein/lane and transferred onto a PVDF membrane (Millipore) using transfer buffer [pH 11.0, 25 mM Tris, 0.2 M glycine, 20% (v/v) methanol] on a semi-dry electroblotter (Bio-Rad). After blocking with 5% skim milk and 0.1% Tween-20 for 1 h at room temperature (RT), AQP1 was detected by incubating the samples with rabbit polyclonal anti-AQP1 and Cx43 antibodies at a 1:1,000 dilution (Abcam Ltd.) overnight at 4°C. Alkaline phosphatase-goat anti-rabbit IgG at a 1:3,000 dilution (GeneTex, Inc., USA) was used as the secondary antibody. The immunoblots were developed using ECL detection reagent (Pierce Chemical).

Lentivirus production and transfection

We obtained the lentivirus packaging system for AQP1 overexpression from Tronolab. The lentivirus packaging system for AQP1 RNAi was obtained from Addgene. The RNAi target sequences were 5′-ATC ATC AGC ATC CAA GGT CAT ACT CC-3′ and 5′-AAG AGC TTC TTC TTG ATT TCG CTG G-3′. Recombinant lentivirus was produced by co-transfecting 293T cells with the expression plasmid and packaging plasmids, and RNAi plasmids and packaging plasmids separately. Infectious cells were harvested at 48 and 72 h post transfection. Cell debris was eliminated by centrifugation. Recombinant lentiviral suspension (200 μg/kg body weight) was injected into the ventricular myocardium of the ventricular wall using 30-gauge syringe. The injection did not cause any hemodynamic changes, allergies, or other side effects during the entire experiment. The empty vector virus was injected in an identical manner and served as the negative control.

Immunofluorescence

Cryosections (8-μm) were fixed with 3% paraformaldehyde in PBS, washed, and incubated in blocking buffer (PBS containing 2% BSA). Primary antibodies diluted in blocking buffer were applied for 1 h at RT, or overnight at 4°C (1:1,000 dilutions for the monoclonal AQP1 antibody; Abcam). Samples were washed with PBS and incubated for 2 h with appropriate secondary antibodies diluted in blocking buffer (Alexa Fluor 488-conjugated donkey anti-rabbit IgG; Molecular Probes-Invitrogen). Samples were washed three times in PBS and mounted using Shandon Immu-mount™. Sections were analyzed with a Leica SP2 confocal laser-scanning microscope.

Analysis of myocardial edema

Myocardial edema was determined according to the water content of the myocardial muscle tissue. The wet weight (WW) of myocardial tissue was weighed using an analytical balance. The samples were then dried using a microwave oven, and the dry weight (DW) was recorded. Water content was calculated using the equation: Water content = (WW - DW)/WW × 100%.

Cardiac function measurement

A micromanometer tipped catheter was positioned in the LV. Hemodynamic parameters were recorded using a data recording unit. Echocardiography was performed using a Sonos 5500 (Hewlett Packard, USA).

Statistical analysis

All values are expressed as the mean ± standard deviation (SD). Statistical analysis was performed by one-way analysis of variance (ANOVA), followed by the Student’s and Newman-Keuls test using SPSS 11.0. A P-value <0.05 was considered to indicate a statistically significant result.

Results

Right and left ventricular expression of AQP1 in goats

The expression of AQP1 in human cardiac muscle is rather high. In our study, goat right and left ventricular mRNA expression levels of AQP1 were detected by real-time PCR, and the results indicated that there was little difference between the right and the left ventricles (P>0.05) (Fig. 1A). The protein levels of AQP1 were also detected by western blot analysis (Fig. 1B). A histogram was created based on the gray values of the western blot analysis (Fig. 1C). The protein level of AQP1 in the left and right ventricles was also nearly identical (P>0.05) (Fig. 1B and C).

Figure 1

mRNA or protein expression of AQP1 and Cx43 in the left and right ventricles of goats. Samples (from six left and six right ventricles) were obtained from 40 kg adult goats (3 males and 3 females). (A) mRNA expression were detected by real-time PCR; each sample was repeated three times. Error bars represent standard deviation (n=6). (B) Protein expression was detected by western blot analysis; each sample was repeated two times using GAPDH as the control. (C) Histogram based on the gray values of the western blot analysis; error bars represent standard deviation (n=6). (D) mRNA expression levels of AQP1 analyzed by real-time PCR at different time-points after cardiopulmonary bypass (CPB) surgery; error bars represent standard deviation (n=6). (E) Protein expression levels of AQP1 were analyzed by ELISA at different time-points after CPB surgery, error bars represent standard deviation (n=6). (F) Protein expression levels of Cx43 were analyzed by western blot analysis at different time-points after CPB surgery (n=6). (G) Quantification of Cx43 protein levels from western blot analysis; data were normalized by corresponding GAPDH. *P<0.05. (H) The water content of myocardial muscle tissue at different time-points after CPB surgery; error bars represent standard deviation (n=6). *P<0.05 vs. 0 h following CPB surgery.

Left ventricular expression of AQP1 and Cx43 after CPB surgery

The mRNA expression of AQP1 was measured by real-time-PCR 0, 2, 6, 12, 24, 48 and 72 h following CPB surgery (Fig. 1D). Initially, mRNA expression decreased after aortic occlusion. Six hours later, the expression began to increase and reached a maximum level after 48 h. Next, the mRNA expression level of AQP1 slowly decreased. The protein expression of AQP1 was measured using ELISA (Fig. 1E), and the expression pattern was similar to mRNA expression. Initially the protein expression decreased, 6 h later the expression level began to increase, 48 h later it reached the peak value, and then the expression level began to slowly decrease. The protein expression of Cx43 (Fig. 1F) detected by western blot analysis, was inversely correlated with AQP1.

Myocardial edema was assessed according to the water content of the myocardial muscle. The water content of the myocardial muscle was measured 2, 6, 12, 24, 48 and 72 h following CPB surgery (Fig. 1H). The degree of myocardial edema increased following the cardiopulmonary surgery, and 48 h later peaked at the same time that the mRNA and protein expression levels of AQP1 reached maximum values. Finally, the water content of the myocardial muscle slowly decreased.

Lentiviral-mediated overexpression of AQP1 causes myocardial edema

Left and right ventricular cells were infected by a lentivirus expressing AQP1 during CPB surgery. The expression of AQP1, as detected by real-time PCR (Fig. 2A–D), and the protein expression of Cx43, detected by western blot analysis (Fig. 2G–H), decreased after infection with the lentivirus expressing AQP1. A similar trend was observed between AQP1 expression levels and the control; however, the quantity of AQP1 protein expression was greater compared to the control (Fig. 2B and D). Myocardial edema was determined by measuring the water content of the myocardial muscle tissue (Fig. 2F). The myocardial edema of the infection group was much greater compared to the control group. The changes of AQP1 protein over time were also measured (Fig. 2E). The trend of the curve correlated with the degree of myocardial edema.

Figure 2

Expression of AQP1 and Cx43 after lentivirus infection. (A) Relative mRNA expression of AQP1 in the left ventricle 48 h post-lentivirus infection. (B) Relative mRNA expression of AQP1 in the left ventricle after lentivirus infection during cardiopulmonary bypass (CPB) surgery. (C) Relative mRNA expression of AQP1 in the right ventricle 48 h post-lentivirus infection. (D) Relative mRNA expression of AQP1 in right ventricle post-lentivirus infection during CPB surgery. (E) Protein expression levels of AQP1 in right ventricle post-lentivirus infection during CPB surgery according to ELISA analysis. (F) Water content of myocardial muscle tissue post-lentivirus infection during CPB surgery. Error bars represent standard deviation (n=6). (G) Protein expression levels of Cx43 in the left and right ventricle 48 h post-lentivirus infection during CPB surgery analyzed by western blot analysis. (H) Quantification of Cx43 protein levels according to western blot analysis; data were normalized by corresponding GAPDH. *P<0.05 vs. empty vector group. Vector, empty vector group; AQP1 OE, AQP1 overexpression group.

Inflammation was observed in conjunction with elevated AQP1 expression following CPB surgery

AQP1 was knocked down following injection of an RNAi lentivirus during CPB surgery. Tissue samples were obtained from the left ventricle. Sections were cut (5 μm) and stained using the standard hematoxylin and eosin staining. The efficiency of knockdown was detected by immunofluorescence staining (Fig. 3B). In the control group, a greater number of nuclei was released from the myocardial cells (Fig. 3A). This finding revealed that inflammation had occurred along with myocardial edema following CPB surgery. Inflammation did not occur in the normal tissue group or in the surgery with lentivirus-infection group. The expression of Cx43 (Fig. 3C) increased in the surgery with lentivirus-infection group compared to the control group; this demonstrated that the inflammation caused by myocardial edema correlated with AQP1 and Cx43 expression.

Figure 3

Tissue sections 48 h after injection of AQP1 RNAi following cardiopulmonary bypass (CPB) surgery and immunolocalization of AQP1. (A) H&E staining of cardiac muscle sections. (B) Detection of AQP1 by immunofluorescence. Compared with normal tissue and tissue sections infected with AQP1 RNAi, there were a greater number of nuclei (arrows) released from cells in the sham control (surgery without lentivirus infection). (C) Protein expression levels of AQP1 and Cx43 were measured by western blot analysis. (D) Quantification of AQP1 and Cx43 protein levels according to western blot analysis; data were normalized by corresponding GAPDH. *P<0.05, **P<0.01 compared to the normal tissue group.

Effect of water channel protein inhibitor Hg2+ on myocardial edema caused by CPB

Hg2+ is a water channel protein inhibitor. During CPB surgery, 3 μM Hg2+ was added to cardioplegia. The mRNA and protein expression levels of AQP1 were measured 2, 6, 12, 24, 48 and 72 h following CPB surgery (Fig. 4A–D). The protein expression of Cx43 was measured 48 h after CPB surgery (Fig. 4E and F). Our results revealed that Hg2+ exhibited no effect on both the left and right ventricular expression of AQP1 (P>0.05). However, the degree of myocardial edema was low compared with the control group.

Figure 4

Expression of AQP1 after Hg2+ treatment and during cardiopulmonary bypass (CPB) surgery and the effects on cardiac function after lentivirus infection. (A) Left ventricular and (C) right ventricular AQP1 mRNA expression levels after Hg2+ treatment during CPB surgery. (B) Left ventricular and (D) right ventricular AQP1 protein expression after Hg2+ treatment during CPB surgery. (E) Protein expression levels of Cx43 in left and right ventricles 48 h after Hg2+ treatment following CPB surgery. (F) Quantification of Cx43 protein levels according to western blot analysis; data were normalized by corresponding GAPDH. (G) Water content of myocardial muscle tissue after Hg2+ treatment during CPB surgery. (H) Representative LVP records, (I) representative positive dP/dt and (J) representative negative dP/dt of vector and AQP1 OE groups. Vector, empty vector group; AQP1 OE, AQP1 overexpression group.

The effect of lentiviral-mediated overexpression of AQP1 on cardiac function following CPB surgery

To confirm the effects of lentiviral-mediated overexpression of AQP1 in myocardial edema, lentiviral vector of AQP1 or empty vector was injected intramuscularly into goats during CPB surgery; cardiac function was then assessed using hemodynamic parameters and catheterization analysis 2, 6, 12, 24, 48 and 72 h following CPB surgery. Catheterization analysis revealed the LV pressure (LVP) of AQP1 lentiviral vector- and empty vector-treated goats (Fig. 4H). In both groups, the LVP gradually recovered following CPB surgery; however, at the 72 h time-point, the LVP of the AQP1 lentiviral vector-treated goats was significantly lower compared to the empty vector-treated goats (AQP1 lentiviral vector, 76.12±7 mmHg; empty vector, 98.03±10 mmHg; P<0.05). Positive and negative dP/dt was used to measure the overall cardiac contractility and relaxation, respectively (17). Positive dP/dt decreased following CPB surgery in the empty vector- and AQP1 lentiviral vector-treated goats (Fig. 4I). The positive dP/dt of the AQP1 lentiviral vector-treated goats was significantly lower compared to empty vector-treated goats 72 h after CPB surgery (AQP1 lentiviral vector, 822±59 mmHg; empty vector, 965±72 mmHg; P<0.05). Moreover, recovery of negative dP/dt after CPB surgery was observed in the empty vector- and AQP1 lentiviral vector-treated goats (Fig. 4J). The negative dP/dt of AQP1 lentiviral vector-treated goats was significantly worse compared to empty vector goats 24 h after CPB surgery (AQP1 lentiviral vector, −1150±126 mmHg; empty vector, −1432±97 mmHg; P<0.05).

Discussion

This study was designed to examine the role of AQP1 in myocardial edema caused by CPB surgery. Additionally, we investigated whether there is a functional relationship between water channels and gap junctions. Using a goat extracorporeal circulation model, we examined APQ1 and Cx43 expression and the degree of myocardial edema during CPB surgery. We found a correlation between increased expression of AQP1 and myocardial edema following CPB surgery. Additionally, overexpression of AQP1 by a lentivirus enhanced myocardial edema and downregulated Cx43 expression.

AQP1 is the ubiquitous water channel protein found in endothelial cell membranes of vascular tissues throughout the body. It is found in the plasma membranes of red blood cells as well as the kidney, lung, brain, and eye (18). Gap junctions are composed primarily of Cx43, which has been previously demonstrated to be an essential element in the protective response of the myocardium to ischemic preconditioning (19).

To date, there are fewer reports on AQPs and their relationship with connexins in the heart when compared to the kidney, brain, eye, and other tissues. The function of AQPs and connexins in the heart is poorly understood, and there is considerable controversy among different studies. AQP1 has been identified in rodent heart and human heart (20), and it has been confirmed that AQP1 is the dominant AQP in the human heart and that it is co-localized with t-tubular and caveolar proteins, in particular.

It has been hypothesized that the transmembrane ion current of myocardial cells, mediated by AQP1, requires rapid equilibrium of internal and external osmotic pressure (21,22). In a previous report, it was demonstrated that AQP1 expression was increased in anemic fetuses compared to age-matched controls, suggesting that AQP1 plays an important role in physiological accommodation to fetal anemia (23). In this study, left ventricular mRNA and protein expression levels of AQP1 were measured following CPB surgery and the water content of myocardial muscle was determined. Our results indicated that cardiac AQP1 plays a role during the osmotic stress of CPB and the osmotic stress that occurs following cardiac edema.

It was previous demonstrated that AQP1 is present in the pulmonary microvascular endothelium, but on the expression of AQP1 decreases in alveolar microvessels upon pulmonary edema in chronic heart failure. It has been hypothesized that downregulation of AQP1 in alveolar microvessels potentially acts as a compensatory mechanism to protect against the formation of excessive pulmonary edema (24). The expression of AQP1 in alveolar microvessels following edema was not observed in this study. This was most likely because AQP proteins in myocardial cells are the major water transport channels; moreover, Hg2+ (AQP protein non-specific inhibitor) limits the extent of myocardial edema. We found no statistically significant differences between mRNA and protein expression levels of AQP1 following Hg2+ treatment during CPB surgery. However, the water content of myocardial muscle tissue significantly decreased after Hg2+ treatment.

In this study, we analyzed the expression level of the main gap junction protein, Cx43; we hypothesized that there is a potential relationship between connexins and aquaporins. Goats with a silenced AQP1 gene exhibit increased Cx43 levels following CPB surgery, suggesting a close relationship between AQP1 and Cx43.

In summary, we found that AQP1 plays a role in myocardial edema following CPB surgery; moreover, a close relationship between AQP1 and Cx43 was demonstrated. Further studies are warranted to investigate potential methods of regulating AQP1 expression in order to control the degree of myocardial edema during surgery.

Acknowledgements

This study was partly supported by grants from the National Natural Science Foundation of China (30872558) and the Science and Technology Foundation of School of Medicine, Shanghai Jiaotong University (2008XJ019).

References

1 

Albers J, Schroeder A, de Simone R, Mockel R, Vahl CF and Hagl S: 3D evaluation of myocardial edema: experimental study on 22 pigs using magnetic resonance and tissue analysis. Thorac Cardiovasc Surg. 49:199–203. 2001. View Article : Google Scholar : PubMed/NCBI

2 

Jia CX, Rabkin DG, Hart JP, Dean DA, Cabreriza SA, Weinberg AD and Spotnitz HM: Regional variation in myocardial water content in the edematous pig heart. J Surg Res. 106:70–75. 2002. View Article : Google Scholar : PubMed/NCBI

3 

Foglia RP, Lazar HL, Steed DL, Follette DM, Manganaro AJ, Deland E and Buckberg GD: Iatrogenic myocardial edema with crystalloid primes: effects on left ventricular compliance, performance, and perfusion. Surg Forum. 29:312–315. 1978.

4 

Laine GA and Allen SJ: Left ventricular myocardial edema. Lymph flow, interstitial fibrosis, and cardiac function. Circ Res. 68:1713–1721. 1991. View Article : Google Scholar : PubMed/NCBI

5 

Spotnitz HM and Hsu DT: Myocardial edema: importance in the study of left ventricular function. Adv Card Surg. 5:1–25. 1994.PubMed/NCBI

6 

Palmer BS, Hadziahmetovic M, Veci T and Angelos MG: Global ischemic duration and reperfusion function in the isolated perfused rat heart. Resuscitation. 62:97–106. 2004. View Article : Google Scholar : PubMed/NCBI

7 

Verkman AS: Physiological importance of aquaporins: lessons from knockout mice. Curr Opin Nephrol Hypertens. 9:517–522. 2000. View Article : Google Scholar : PubMed/NCBI

8 

Verkman AS: Aquaporin water channels and endothelial cell function. J Anat. 200:617–627. 2002. View Article : Google Scholar : PubMed/NCBI

9 

King LS, Kozono D and Agre P: From structure to disease: the evolving tale of aquaporin biology. Nat Rev Mol Cell Biol. 5:687–698. 2004. View Article : Google Scholar : PubMed/NCBI

10 

Page E, Winterfield J, Goings G, Bastawrous A and Upshaw-Earley J: Water channel proteins in rat cardiac myocyte caveolae: osmolarity-dependent reversible internalization. Am J Physiol. 274:H1988–H2000. 1998.

11 

Umenishi F, Verkman AS and Gropper MA: Quantitative analysis of aquaporin mRNA expression in rat tissues by RNase protection assay. DNA Cell Biol. 15:475–480. 1996. View Article : Google Scholar : PubMed/NCBI

12 

Nielsen S, Smith BL, Christensen EI and Agre P: Distribution of the aquaporin CHIP in secretory and resorptive epithelia and capillary endothelia. Proc Natl Acad Sci USA. 90:7275–7279. 1993. View Article : Google Scholar : PubMed/NCBI

13 

Boengler K, Dodoni G, Rodriguez-Sinovas A, Cabestrero A, Ruiz-Meana M, Gres P, Konietzka I, Lopez-Iglesias C, Garcia-Dorado D, Di Lisa F, et al: Connexin 43 in cardiomyocyte mitochondria and its increase by ischemic preconditioning. Cardiovasc Res. 67:234–244. 2005. View Article : Google Scholar : PubMed/NCBI

14 

Gorbe A, Varga ZV, Kupai K, Bencsik P, Kocsis GF, Csont T, Boengler K, Schulz R and Ferdinandy P: Cholesterol diet leads to attenuation of ischemic preconditioning-induced cardiac protection: the role of connexin 43. Am J Physiol Heart Circ Physiol. 300:H1907–H1913. 2011. View Article : Google Scholar : PubMed/NCBI

15 

Ruiz-Meana M, Rodriguez-Sinovas A, Cabestrero A, Boengler K, Heusch G and Garcia-Dorado D: Mitochondrial connexin43 as a new player in the pathophysiology of myocardial ischaemiareperfusion injury. Cardiovasc Res. 77:325–333. 2008. View Article : Google Scholar : PubMed/NCBI

16 

Gross C, Nakamoto M, Yao X, Chan CB, Yim SY, Ye K, Warren ST and Bassell GJ: Excess phosphoinositide 3-kinase subunit synthesis and activity as a novel therapeutic target in fragile X syndrome. J Neurosci. 30:10624–10638. 2010. View Article : Google Scholar : PubMed/NCBI

17 

Parsa CJ, Matsumoto A, Kim J, Riel RU, Pascal LS, Walton GB, Thompson RB, Petrofski JA, Annex BH, Stamler JS, et al: A novel protective effect of erythropoietin in the infarcted heart. J Clin Invest. 112:999–1007. 2003. View Article : Google Scholar : PubMed/NCBI

18 

Egan JR, Butler TL, Au CG, Tan YM, North KN and Winlaw DS: Myocardial water handling and the role of aquaporins. Biochim Biophys Acta. 1758:1043–1052. 2006. View Article : Google Scholar : PubMed/NCBI

19 

Garcia-Dorado D, Ruiz-Meana M, Padilla F, Rodriguez-Sinovas A and Mirabet M: Gap junction-mediated intercellular communication in ischemic preconditioning. Cardiovasc Res. 55:456–465. 2002. View Article : Google Scholar : PubMed/NCBI

20 

Butler TL, Au CG, Yang B, Egan JR, Tan YM, Hardeman EC, North KN, Verkman AS and Winlaw DS: Cardiac aquaporin expression in humans, rats, and mice. Am J Physiol Heart Circ Physiol. 291:H705–H713. 2006. View Article : Google Scholar : PubMed/NCBI

21 

Au CG, Cooper ST, Lo HP, Compton AG, Yang N, Wintour EM, North KN and Winlaw DS: Expression of aquaporin 1 in human cardiac and skeletal muscle. J Mol Cell Cardiol. 36:655–662. 2004. View Article : Google Scholar : PubMed/NCBI

22 

Suleymanian MA and Baumgarten CM: Osmotic gradient-induced water permeation across the sarcolemma of rabbit ventricular myocytes. J Gen Physiol. 107:503–514. 1996. View Article : Google Scholar : PubMed/NCBI

23 

Jonker S, Davis LE, van der Bilt JD, Hadder B, Hohimer AR, Giraud GD and Thornburg KL: Anaemia stimulates aquaporin 1 expression in the fetal sheep heart. Exp Physiol. 88:691–698. 2003. View Article : Google Scholar : PubMed/NCBI

24 

Mullertz KM, Strom C, Trautner S, Amtorp O, Nielsen S, Christensen S, Haunso S and Jonassen TE: Downregulation of aquaporin-1 in alveolar microvessels in lungs adapted to chronic heart failure. Lung. 189:157–166. 2011. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Yan Y, Huang J, Ding F, Mei J, Zhu J, Liu H and Sun K: Aquaporin 1 plays an important role in myocardial edema caused by cardiopulmonary bypass surgery in goat. Int J Mol Med 31: 637-643, 2013.
APA
Yan, Y., Huang, J., Ding, F., Mei, J., Zhu, J., Liu, H., & Sun, K. (2013). Aquaporin 1 plays an important role in myocardial edema caused by cardiopulmonary bypass surgery in goat. International Journal of Molecular Medicine, 31, 637-643. https://doi.org/10.3892/ijmm.2013.1228
MLA
Yan, Y., Huang, J., Ding, F., Mei, J., Zhu, J., Liu, H., Sun, K."Aquaporin 1 plays an important role in myocardial edema caused by cardiopulmonary bypass surgery in goat". International Journal of Molecular Medicine 31.3 (2013): 637-643.
Chicago
Yan, Y., Huang, J., Ding, F., Mei, J., Zhu, J., Liu, H., Sun, K."Aquaporin 1 plays an important role in myocardial edema caused by cardiopulmonary bypass surgery in goat". International Journal of Molecular Medicine 31, no. 3 (2013): 637-643. https://doi.org/10.3892/ijmm.2013.1228
Copy and paste a formatted citation
x
Spandidos Publications style
Yan Y, Huang J, Ding F, Mei J, Zhu J, Liu H and Sun K: Aquaporin 1 plays an important role in myocardial edema caused by cardiopulmonary bypass surgery in goat. Int J Mol Med 31: 637-643, 2013.
APA
Yan, Y., Huang, J., Ding, F., Mei, J., Zhu, J., Liu, H., & Sun, K. (2013). Aquaporin 1 plays an important role in myocardial edema caused by cardiopulmonary bypass surgery in goat. International Journal of Molecular Medicine, 31, 637-643. https://doi.org/10.3892/ijmm.2013.1228
MLA
Yan, Y., Huang, J., Ding, F., Mei, J., Zhu, J., Liu, H., Sun, K."Aquaporin 1 plays an important role in myocardial edema caused by cardiopulmonary bypass surgery in goat". International Journal of Molecular Medicine 31.3 (2013): 637-643.
Chicago
Yan, Y., Huang, J., Ding, F., Mei, J., Zhu, J., Liu, H., Sun, K."Aquaporin 1 plays an important role in myocardial edema caused by cardiopulmonary bypass surgery in goat". International Journal of Molecular Medicine 31, no. 3 (2013): 637-643. https://doi.org/10.3892/ijmm.2013.1228
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team